Last update Jan. 15, 2021
Very Low Risk
Sulfonylurea that stimulates endogenous insulin secretion. May cause hypoglycemia.
Indicated in the treatment of type 2 diabetes.
Oral administration in one to three doses daily.
It is excreted in breast milk in clinically insignificant amounts (Moiel 1967).
Experts authors consider the use of this medication to be safe during breastfeeding (Serrano 2015).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
Diet, exercise, and breastfeeding improve blood sugar levels.
Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM